Document 8MmgpNVE6z30NdER3ejVbZoZ
cL SM Specialy Materiel
Spcaone 551641000 SS i
AR 286 _ 1029
May 23, 2001
CDrh.emCihcaarlleCsonAtureorl, DDiivriescitoonr/U.S. EPA O4f0f1icMe oSftrPeoelt,luSt.ioWn.,PrMeavielntCioondean7d40T5oxics Washington, DC 20460-0001
Dr. US
Oscar Hernandez EPA/OPPT/CCD
(7405)
401 M Street, S.W.
Room E615B Washington, DC
20460-0001
Gentlemen:
nAovtaiccehefdorfSorulyfoounratien-fboarsmeadtainond iCsaarbcooxpyyico-fbaasreecdenatnd3CMarfbiloixnygloicfa-baTsSeCdAFl8uo(r)ocShuepmpilceamles.ntaTlhis `notice reported on completed analyses of several fluorochemical compounds in individual, stored human sera.
aWreraanrgee
pwriotvhidyionug
aynodu
Dar.coLpayrroyfthZoibselno,tiMceediicnaplreDpiarreacttioorn
of 0
3aMc.onference|
calIl
would
like
to
{will be in contact with you to arrange a mutually acceptable schedule for that call
In the meantime, if you have any questions, please contact me at 651 733-6374.
Sincerely.
dnl 7 JlE=T
Michael A. S/antoro Director, Environmental,
Health,
Safety
&
Regulatory
Affairs
S3pMeciCaelnttyerMaBtiedrgi.al23M6a-r1kBe-ts10Group
St. Paul, Minnesota 55144
S5g om 238 8 G2
C: Dr. Larry Zobel - 220-2602
b~eS F
Contain NO CBI
3M Genera Offices
3SFMECEEonWe sta.1000
May 15.2001
SIV
DAoTcTuNm:enStecPtriooncs3s(ie)ngCoCoerndtienrat(o7r407) SUSrExvoiroanmennt,al PvroetenctioonmAgsesacTyox W4a0s1hiMngSitroene,t,DS.CW. 20460
RceuimbTeSrCsASE8H(eQ)-S1u1p8p0l-e5m7e3n;taSlEnHQo-c11f8o0r-3S7l4f;onSaEeH-Qs-a0s3e8d1.n0d39C4a;bSorEyHlQi0c9b8as:e3d7F3uorochermcals-Docket
Dear Dosker Coordinator:
5M recently compleced analysesofseveral Suoroshemical compounds i individual, sored buman sera Wncoeamephoaucvnuedrpscr.aetvTiaoanuabslilyyse|rsre,eppoirrnetdseievdnitrdseusasullatmsspoalfeppsesrofflw$ue9orreodomicvetiaadneusasuluslrffooefrnrastuoel2fmf3oornfabetuerbmeaansntesdesraaatnedfcsoarnmtbohpxoeyollUieScd.bsaaismpheleedsa.ge SSeons2-a1c3r.osTshheeseUnsiatmepdleSsatweesr,edforcaunsimnigni19h95e.aTgeabspla2en r2e0p6r9e.senTtsheosveersa6m0p0lensdiwveirceuadlrsafwn rs2i0xob0l0o.mo3dM ill senda al repor ontessanalyses 0 the EPA in te nar ure.
C Tablet. Summo ary of Samplesm Drawn n 1995,p iAgens n 2:12 opeet l [Wane
EFETES FCO SoTsahe
50000-- ShilmS-- eisrm
5
T[S im
Tovw
--TSiiooY -- Ta) [<cioa00zD sm |
Baisoo!er | Time
[;om
T[=ES
[roeTE ||
CPoEsSKON T| oe
Viste
BES
Te TES
|TmTe
oq SoG
{|cChFicSoOsNH- | FO CFC 38am
|
Er
||TT0Zan [SIrogseT
0 ob 5 pars pe ilon: (BYELLOQ ss han te ower TiofquaasFcaion
CToambpl2oe.uSnudmmaryoBlAovoerdagBeank EN FEA
SamplesT DiMerdtaianin 2000, FocusinTg9o5%soenApegrceesnt2i0le-69 Sti
e CHTSrsoCcEO T| Toe e Taimme [| Tvoem [mTeoase ms]||i
JSE : 4fEeo2es---- ETmew w TyE|o m | Twe i Re ||
VCCiFsriSnoOsNo"n: "Toy
:|--
I |
1
|
Ci.Co;
| |
Fron CFO Tow
R32)
TE
mes
Section 8(e) Coordinator May 15,2000 Page2 Pleasecontact meat 651-733-5131foradditonal questionsrelativeto the above analyses. Sincerely, SLtaarfrfyViceZoPbreels,idMenDt M&PMHedical Director 3M Medical Department ((21)) PLerfeuo1r0aoTocStrCaAne8S(uel)fCoon-atoer:dinCautrorre,ntMSauymm15a,r1y9o9f8Human Sera and Toxicology, January 21, 1999.
+